Botulinum toxin is an exceedingly potent inhibitor of neurotransmission across the neuromuscular junction, causing flaccid paralysis and death. The potential for misuse of this deadly poison as a bioweapon has added a greater urgency to the search for effective therapeutics. The development of sensitive and efficient cell-based assays for the evaluation of toxin antagonists is crucial to the rapid and successful identification of therapeutic compounds. The authors evaluated the sensitivity of primary cultures from 4 distinct regions of the embryonic chick nervous system to botulinum neurotoxin A (BoNT/A) cleavage of synaptosomal-associated protein of 25 kD (SNAP-25). Although differences in sensitivity were apparent, SNAP-25 cleavage was detectable in neuronal cells from each of the 4 regions within 3 h at BoNT/A concentrations of 1 nM or lower. Co-incubation of chick neurons with BoNT/A and toxin-neutralizing antibodies inhibited SNAP-25 cleavage, demonstrating the utility of these cultures for the assay of BoNT/A antagonists. (Journal of Biomolecular Screening 2007:370-377) 
INTRODUCTION

T
HE ABILITY OF MINUTE QUANTITIES of botulinum neurotoxin (BoNT) to cause flaccid paralysis and death has led to the reputation of BoNT as the world's most deadly poison. [1] [2] [3] Despite modern improvements in food production and storage processes, cases of food-borne botulism continue to occur, including a recent large-scale outbreak in a village in Thailand. 4, 5 In addition to environmental and accidental 6 exposures, intentional intoxication as an act of terrorism must, unfortunately, also be considered a serious threat. 1, 7 Although a vaccine against BoNT may be feasible for limited use in populations at high risk, wide-scale vaccination would not be practical, partly because vaccination would interfere in the wide variety of medical and cosmetic uses of the toxin. Although BoNT has found use as a treatment for conditions such as dystonia, hyperhidrosis, migraine headaches, and chronic back pain, [8] [9] [10] there is a lack of therapeutics available to treat BoNT intoxication (botulism) itself. If administered early, antitoxin antibodies can help limit the progression of BoNT-induced paralysis. However, botulism patients are often largely dependent on longterm supportive care that includes mechanical ventilation (for several months in severe cases) until natural recovery from BoNTinduced paralysis begins. 6 Clearly, development of therapeutics to aid in recovery from botulism is highly desirable. Consequently, there is a need for improved means to test potential therapeutics.
BoNTs comprise 7 related but immunologically distinct serotypes (designated A-G) produced by the anaerobic bacterium Clostridium botulinum. 2, 3 BoNTs are composed of a heavy chain (100 kD) that is responsible for binding and entry of the toxin into neurons, linked by a disulfide bridge to a light chain (50 kD) that contains a zinc endopeptidase. 2, 3, 11 The enzymatic activity cleaves 1 or more soluble N-ethylmaleimide-sensitive factor attachment protein receptor proteins, critical for synaptic vesicle docking and fusion and hence release of neurotransmitter into the neuromuscular junction. BoNT/A and E cleave synaptosomalassociated protein of 25 kD (SNAP-25); BoNT/B, D, F, and G cleave synaptobrevin (also known as vesicle-associated membrane protein) 2, 12, 13 ; and BoNT/C cleaves both syntaxin and SNAP-25.
14 Much of the current search for potential therapeutics has focused on high-throughput, cell-free identification of smallmolecule antagonists of the enzymatic activity. [15] [16] [17] Investigators are limited, however, in their ability to assess the efficacy of these inhibitors in living cells and to evaluate additional critical parameters such as potential toxicity or ability to traverse cell membranes. Although testing in live intoxicated animals may ultimately be necessary, it is impractical to test large numbers of potential inhibitors initially identified as hit or lead compounds by high-throughput screening or other cell-free assays. Cellular assays have been developed, but many rely on cultured cell lines that have a low sensitivity to the toxin 18 or make use of primary mammalian neurons that can be technically challenging and time-consuming to culture and require the use of pregnant adult animals. 19 In contrast, chicken embryos represent a relatively inexpensive and easily maintained source of primary neurons, conveniently packaged in eggs. Here we report the sensitivities of 4 types of primary chick neuronal cells to BoNT/A as assayed by Western blot analysis of SNAP-25 cleavage. We further show data validating the usefulness of chicken neurons for cell-based evaluation of toxin antagonists.
MATERIALS AND METHODS
Neuronal cultures
Embryonic chicken spinal motor neurons were cultured by the method described in detail by Kuhn. 20 In brief, fertilized chicken eggs (SPAFAS/Charles River Laboratories, North Franklin, CT) were incubated at 37 °C for 6 days. Embryos were removed from the eggs and spinal cords dissected from the embryos. The dorsal half of each spinal cord was cut away, leaving the motor neuron-rich ventral half. Cells were dissociated by trypsinization followed by trituration. Cells were preplated into a culture dish with Dulbecco's modified Eagle's medium plus 10% fetal bovine serum (FBS) for 1 h to allow nonneuronal cells to attach to the dish and thereby increase the percentage of neuronal cells in the suspension. Cells were centrifuged and resuspended in Leibovitz L15 medium (Gibco/Invitrogen, Carlsbad, CA) with N3 supplement, 5-fluoro-2′-deoxyuridine, and 10% FBS.
Forebrain neurons were cultured from embryonic chicks after 8 days of incubation following the procedure of Heidemann and colleagues. 21 In brief, the forebrain was removed from the embryonic chicken skull with forceps, and the meningeal layers were stripped away. The tissue was trypsinized and triturated to dissociate the cells. The cells were plated in Leibowitz L15 medium with 10% FBS, 0.6% glucose, 2 mM glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, 100 ng/ml 7 S nerve growth factor, and the N9 supplements described by Heidemann and coworkers. 21 Sympathetic and dorsal root ganglion neurons were isolated and cultured from chicken embryos after 9 to 11 days of incubation, essentially as described by Bray and others. 22 After trypsinization and mechanical dissociation of the respective tissues, cells were plated in Leibowitz L15 medium with 10% FBS, 0.6% glucose, 2 mM glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, and 50 ng/ml 2.5 S nerve growth factor.
Neuro-2a (N2a) neuroblastoma cells (ATCC, Manassas, VA) were grown in Eagle's Minimum Essential Medium with 10% FBS.
For each of the cell types described above, cells were plated into 6-well tissue culture plates that were coated first with poly-L-lysine (1 mg/ml; Sigma, St. Louis, MO), then with laminin (6 µg/ml; Invitrogen, Carlsbad, CA). All cells were incubated overnight at 37 °C prior to intoxication.
Intoxication and Western blot analysis
BoNT/A (MetaBiologics Inc., Madison, WI) was applied to cells by replacing the culture medium with medium that contained the desired concentration of toxin. Cells were incubated in BoNT/A at 37 °C for 3 h, except where otherwise noted. Because toxin preparations can vary widely in efficiency of SNAP-25 cleavage, all results presented were performed using BoNT/A from a single batch. Cleavage of SNAP-25 was assessed using Western blot analysis. Following incubation, intoxicated cells were rinsed with fresh culture medium, collected, washed in phosphate-buffered saline, lysed, and assessed for protein content using the Bradford protein assay (BioRad, Hercules, CA). Cell lysates were run on a 12% Tris-Glycine gel (Invitrogen, Carlsbad, CA) and probed with SMI 81 mouse anti-SNAP-25 (Sternberger Monoclonals Incorporated, Lutherville, MD) and mouse anti-GAPDH (Covance Research Products Inc., Berkeley, CA) primary antibodies. A horseradish peroxidase-conjugated goat antimouse secondary antibody was used (Pierce, Rockford, IL) in combination with an ECL Western blotting detection system (Pierce). Band densities were determined with UN-SCAN-IT software (Silk Scientific, Orem, UT). For SNAP-25 cleavage inhibition studies, antistaphylococcal enterotoxin B (αSEB), BoNT/B neutralizing, or BoNT/A neutralizing antibodies (all produced in the U.S. Army Medical Research Institute of Infectious Diseases) were preincubated for 30 min with BoNT/A before addition to the cells. Cell cultures were prepared for Western blots as described above.
Microscopy
Confocal microscopy images were collected using a BioRad Radiance 2000MP confocal/multiphoton system (Zeiss, Thornwood, NY) attached to a Nikon TE300 inverted microscope. Neuronal cells were fixed for 30 min in 3.7% formaldehyde and permeabilized in 0.2% Triton-X-100 for 10 min. Cells were blocked for 30 min in 1% bovine serum albumin and then incubated with 1:500 TuJ-1 anti-neuron-specific beta-III tubulin (R&D Systems, Minneapolis, MN). Following this, cells were labeled with 1:500 Alexa 488 conjugated goat antimouse secondary antibody, 1:25 Texas red phalloidin, and Hoechst stain (Molecular Probes, Eugene, OR).
RESULTS
Sensitivity of chick neuronal cells to BoNT/A
To determine the sensitivity to BoNT/A of dissociated neurons cultured from various regions of the chicken nervous system, we treated neurons from the ventral spinal cord, sympathetic ganglia, dorsal root ganglia (DRG), and forebrain with various concentrations of BoNT/A for 3 h. For comparison, N2a cells, an established cell line derived from mouse neuroblastoma, were incubated with BoNT/A for 3 h and 48 h. N2a cells have previously been shown to be susceptible to BoNT/A after a 48-h incubation. 23 Photographs demonstrating the morphology of typical cells from each of these various cultures are shown in Figure 1 . The heterogeneity of morphologies displayed by N2a cells was striking compared to the relative uniformity in shape of the chicken neurons (neurons were stained with a neuron-specific tubulin antibody, shown in green). We assessed the degree of SNAP-25 cleavage through the use of Western blot analysis (Fig. 1) . Although nonneuronal cells were present in the primary cultures, it is unlikely that they contributed appreciably to the results, as nonneuronal cells isolated by the preplating of ventral spinal cord cultures and allowed to proliferate to confluency yielded no detectable levels of SNAP-25 in Western blots (data not shown). The Western blots, and the accompanying graphs of band-density ratios (cleaved/intact SNAP-25), clearly demonstrate that SNAP-25 cleavage occurred in all of the chick primary neuronal cultures within 3 h of exposure at concentrations of BoNT/A as low as 1 nM. In stark contrast, no cleavage was detectable in N2a cells at 10 nM within the same time frame. Little cleavage of N2a SNAP-25 was apparent even at concentrations as high as 100 nM or at incubation times as long as 48 h at 10 nM. The Western blot data described above suggested that, of the 4 regions of the chicken nervous system that we tested, the ventral spinal cord cells seemed to be the most sensitive to the toxin. Therefore, we continued by examining the sensitivity of these cells to picomolar concentrations of BoNT/A. As shown in Figure 2 , SNAP-25 cleavage is apparent in these cells even at toxin concentrations as low as 50 pM within 3 h. To examine the time course of toxin action, we exposed the ventral spinal cord cell cultures to 10 nM BoNT/A for various durations and again examined SNAP-25 cleavage by Western blot analysis (Fig. 3) . Although no SNAP-25 cleavage was discernible by 30 min, a band of cleaved SNAP-25 was clearly visible within 1 h. After only 3 h, well more than half the SNAP-25 had been cleaved, and by 24 h, only a faint band of uncleaved protein remained.
Evaluation of BoNT/A antagonists
For chick neuron cultures to be useful for the evaluation of toxin inhibitors, it must be possible to observe a decrease in BoNT/A-dependent SNAP-25 cleavage in the presence of a toxin antagonist. Therefore, we tested the ability of BoNT/A neutralizing antibodies to prevent the cleavage of SNAP-25 that we had observed in the presence of BoNT/A (Fig. 4) . These antibodies were already known to be capable of rescuing mice from BoNT/A-induced death. 24 We chose to test the BoNT/A neutralizing antibodies with both ventral spinal cord and forebrain cultures because these 2 cultures represent very different advantages with regard to their potential use in assays. The ventral spinal cord culture proved to be extremely sensitive to the toxin in the Western blot experiments described above. In addition, the motor neurons in this culture are particularly relevant for in vivo intoxication. However, the dissection is relatively time-consuming (typically 10-15 min per embryo), and the yield is rather low (approximately 200,000 cells per embryo). Forebrain neurons, which would normally be protected from intoxication in vivo by the blood-brain barrier, proved to be less sensitive to BoNT/A. However, the forebrain dissection can be completed in a matter of only a few minutes, and each forebrain typically yields more than 10 million cells, making this an attractive neuronal culture for assay use. As shown in Figure 4 , Western blot analyses revealed inhibition of SNAP-25 cleavage in the presence of neutralizing antibodies but not control antibodies for both the ventral spinal cord and forebrain cultures. Furthermore, an expected inverse relation of the amount of antibody added to the extent of SNAP-25 cleavage was readily apparent from an examination of the blots.
DISCUSSION
We have evaluated primary cultures from 4 regions of the chick nervous system (ventral spinal cord, sympathetic ganglia, DRG, and forebrain) for potential usefulness in the study of BoNT/A and the assay of BoNT/A antagonists. Approximately 50% SNAP-25 cleavage can be achieved in cells from each of these 4 regions of the nervous system with concentrations of BoNT/A at least as low as 1 to 10 nM within 3 h of exposure. This demonstrable sensitivity to the toxin combined with the relative ease and low cost of preparing any of these embryonic chick neuronal cultures makes them attractive model systems for the study and assay of BoNT and potential inhibitors of the toxin. The readily apparent inhibition of SNAP-25 cleavage that resulted from the addition of BoNT/A neutralizing antibodies further indicates the potential utility of the chick neuron model system for the assay of BoNT antagonists.
Cell-based assays are an important step in the identification of potential future therapeutics for botulism, the discovery of which has recently taken on greater importance due to heightened fears of bioterrorism and due to the increasing medical uses of BoNT/A that would be mitigated by vaccination. Although in vitro assays offer high-throughput means of discovering inhibitors of BoNT enzymatic activity, they cannot distinguish inhibitors that act by other means such as inhibition of toxin entry into cells. Likewise, they provide no information regarding the potential cytotoxicity of compounds identified. On the other hand, mouse lethality studies offer information on in vivo efficacy of potential therapeutics but are too costly and time-consuming to be used to test every potential BoNT inhibitor identified in cell-free enzyme cleavage assays. Cell-based models fill the gap. Current cell models available include cell lines, such as N2a or SH-SY5Y, 18 ,23 that typically have low sensitivity to the toxin and require intoxication times of 48 h or more. Primary cultures of mammalian neurons provide the toxin sensitivity lacking in cell lines but require the use of pregnant adult animals and often involve relatively complicated dissections of the embryos. Our results suggest that primary cultures of embryonic chicken neurons combine an ease of use (particularly in the case of the forebrain culture) approaching that of cell lines with a sensitivity to toxin comparable to mammalian systems (with greatest sensitivity in the ventral spinal cord cultures, followed closely by sympathetic ganglion cultures).
Importantly, our results suggest that primary cultures of chicken neurons may be useful as a means of reducing the need for mouse BoNT lethality studies. With further standardization, use of Western blotting techniques after chick neuron intoxication may offer an alternative to mouse LD 50 studies for determining BoNT potency. Similarly, chick neurons can provide a means for prescreening potential inhibitors prior to testing in a whole animal model. Indeed, our tests with BoNT/A neutralizing antibodies provided evidence of efficacy well in line with published mouse lethality studies. 24 In addition, we have been able to determine through simple visual inspection of inhibitortreated chick neurons that a number of compounds that potently inhibited BoNT/A enzymatic activity were highly cytotoxic (unpublished observations).
The results of the Western blot experiments described herein indicate that primary neuronal cultures from chick ventral spinal cord, sympathetic ganglia, DRG, and forebrain display somewhat different sensitivities to BoNT/A. Interestingly, the cells that appeared to be the most sensitive were from the ventral spinal cord, which predominantly contains cholinergic spinal motor neurons that synapse on skeletal muscle. It is the intoxication of these cells that is responsible for the flaccid paralysis associated with botulism. In contrast, forebrain neurons, which are normally shielded from the toxin by the blood-brain barrier in vivo, were much less sensitive to BoNT/A. Although the underlying basis for the differences in sensitivity is uncertain, previous reports have suggested that differences in cell surface toxin receptors may determine toxin sensitivity. 18 Work by Dong and colleagues 25 has implicated synaptic vesicle protein SV2 in BoNT/A binding to N2a cells. SV2 receptor expression may vary in different neuronal populations, providing a rationale for the subtle differences in sensitivity seen among the different types of chick neurons as well as the vast difference in sensitivity of these neurons when compared to N2a cells. Future studies may elucidate the potential connection between abundance of surface receptor and relative susceptibilities to SNAP-25 cleavage. To further guide our studies on the sensitivity of these primary cells, we are trying to quantify the amounts of SV2 on primary embryonic chicken neurons and compare the abundance of this receptor on the surface of the chick neurons to N2a cells.
Regardless of the underlying molecular basis for the observed differences in sensitivity to BoNT/A, the particularly high sensitivity of chick ventral spinal cord cells may make them useful for biological detection of the toxin. On the other hand, the particular ease with which the forebrain cultures can be prepared, despite a somewhat lower sensitivity to BoNT/A, may make them suitable for future development of high-throughput cell-based assays. Furthermore, we are working to show the sensitivity of primary embryonic chicken neurons to other BoNTs.
CONCLUSIONS
In this article, we described a cellular assay that can be used to evaluate potential therapeutic inhibitor compounds of BoNT/A. Much research has focused on the identification of an efficacious therapeutic product that can ameliorate or eliminate the neurotoxic effects of BoNT. Although numerous biochemical assays exist to evaluate in vitro enzymatic inhibition, in vivo cell-based assays are needed to evaluate the ability of compounds to traverse the neuronal cell membrane and neurotoxicity. Our assay uses easily harvested primary neuronal cells from 6-to 9-day-old chick embryos and Western blotting techniques to evaluate cleavage of the BoNT/A substrate SNAP-25. With the addition of basic microscopy, the neurotoxicity of potential inhibitors can be easily assessed. Importantly, primary cells demonstrate a far greater sensitivity to BoNT/A than N2a or other cultured neuronal cell lines, allowing for greatly reduced assay time and toxin requirements. Thus, they are an ideal platform for BoNT high-throughput assay development.
